Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
J Med Virol. 2014 Oct;86(10):1752-8. doi: 10.1002/jmv.23917. Epub 2014 Mar 12.
Bell's palsy is the most common cause of facial paralysis. Although it has been associated with diabetes mellitus, hypertension, pregnancy, and preeclampsia, the etiology of Bell's palsy remains unknown. The reactivation of latent herpes simplex virus (HSV) or varicella-zoster virus (VZV) with subsequent inflammation and entrapment of the facial nerve in the narrow labyrinthine segment has been implicated as a cause of facial paralysis, but the active role of these viruses in Bell's palsy is still discussed. This study quantified HSV-1 DNA, VZV DNA, and HHV-6 DNA in 95 saliva samples collected from patients within 48 hr from the onset of paralysis. HSV-1, VZV, and HHV-6 were detected in 13%, 3%, and 61% of patients, respectively. The detection rate did not differ significantly between patients and a control group of healthy donors. Interestingly, however, the value of HHV-6 DNA copies was significantly higher than that detected in healthy donors. In addition, the mean value of HHV-6 DNA recorded in patients who had at least a one grade improvement of palsy at the first visit was significantly lower than that detected in patients who showed no change in facial palsy grade or an increase of at least one grade. These findings call into question the role of HSV-1 and VZV in the etiology of Bell's palsy, and suggest that HHV-6 may be involved in the development of the disease or that the underlying disease mechanism might predispose patients to HHV-6 reactivation.
贝尔麻痹是最常见的面部瘫痪原因。尽管它与糖尿病、高血压、妊娠和子痫前期有关,但贝尔麻痹的病因仍不清楚。潜伏的单纯疱疹病毒(HSV)或水痘-带状疱疹病毒(VZV)的再激活,随后炎症和面神经在狭窄的迷路段的被困,被认为是导致面瘫的原因,但这些病毒在贝尔麻痹中的积极作用仍在讨论中。本研究在发病后 48 小时内从 95 名患者的唾液样本中定量检测了 HSV-1 DNA、VZV DNA 和 HHV-6 DNA。在分别为 13%、3%和 61%的患者中检测到 HSV-1、VZV 和 HHV-6。患者与健康对照组之间的检测率无显著差异。然而,有趣的是,HHV-6 DNA 拷贝的数值明显高于健康对照组。此外,在首次就诊时至少有一级面瘫改善的患者中记录的 HHV-6 DNA 的平均值明显低于面瘫分级无变化或至少增加一级的患者。这些发现质疑 HSV-1 和 VZV 在贝尔麻痹病因中的作用,并表明 HHV-6 可能参与疾病的发展,或者潜在的疾病机制可能使患者易发生 HHV-6 再激活。